153 related articles for article (PubMed ID: 33154305)
1. Neuroendocrine carcinomas of the breast: Case series with review of literature.
Singh V; Kaur N; Mandal S; Mallya V; Tomar R; Khurana N; Bains L
Indian J Pathol Microbiol; 2020; 63(4):559-563. PubMed ID: 33154305
[TBL] [Abstract][Full Text] [Related]
2. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
[TBL] [Abstract][Full Text] [Related]
3. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
Kelten Talu C; Savli TC; Huq GE; Leblebici C
Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in breast carcinoma with osteoclast-like giant cells. Report of a case and review of the literature.
Cozzolino I; Ciancia G; Limite G; Di Micco R; Varone V; Cortese A; Vatrella A; Di Crescenzo V; Zeppa P
Int J Surg; 2014; 12 Suppl 2():S8-S11. PubMed ID: 25204617
[TBL] [Abstract][Full Text] [Related]
5. Solid neuroendocrine carcinoma of the breast: a rare tumor.
Zizi-Sermpetzoglou A; Kontostolis V; Moustou E; Koulia K; Kouroumpas E; Myoteri D; Arkoumani E
Eur J Gynaecol Oncol; 2014; 35(3):325-7. PubMed ID: 24984553
[TBL] [Abstract][Full Text] [Related]
6. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.
Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z
Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiated carcinomas of the breast: a distinct entity.
Zekioglu O; Erhan Y; Ciriş M; Bayramoglu H
Breast; 2003 Aug; 12(4):251-7. PubMed ID: 14659309
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
Bogina G; Munari E; Brunelli M; Bortesi L; Marconi M; Sommaggio M; Lunardi G; Gori S; Massocco A; Pegoraro MC; Zamboni G
Histopathology; 2016 Feb; 68(3):422-32. PubMed ID: 26114478
[TBL] [Abstract][Full Text] [Related]
10. Primary neuroendocrine carcinoma of the breast: a 5-year experiences.
Canbak T; Acar A; Tolan HK; Ozbagriacik M; Ezberci F
Ann Ital Chir; 2020; 91():23-26. PubMed ID: 32180568
[TBL] [Abstract][Full Text] [Related]
11. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
12. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
Ding HY; Gao LX
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
Miremadi A; Pinder SE; Lee AH; Bell JA; Paish EC; Wencyk P; Elston CW; Nicholson RI; Blamey RW; Robertson JF; Ellis IO
Histopathology; 2002 Mar; 40(3):215-22. PubMed ID: 11895486
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.
Makretsov N; Gilks CB; Coldman AJ; Hayes M; Huntsman D
Hum Pathol; 2003 Oct; 34(10):1001-8. PubMed ID: 14608533
[TBL] [Abstract][Full Text] [Related]
17. [Breast carcinoma with predominant neuroendocrine differentiation].
Frachon S; Pasquier D; Treilleux I; Seigneurin D; Ringeisen F; Rosier P; Bolla M; Boutonnat J
Ann Pathol; 2004 Jun; 24(3):278-83. PubMed ID: 15480266
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
[TBL] [Abstract][Full Text] [Related]
19. Mucinous carcinoma of the breast: a comparative study on cytohistological findings associated with neuroendocrine differentiation.
Ohashi R; Sakatani T; Matsubara M; Watarai Y; Yanagihara K; Yamashita K; Tsuchiya S; Takei H; Naito Z
Cytopathology; 2016 Jun; 27(3):193-200. PubMed ID: 26804749
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
